1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Xevinapant: new trials by email Literature Review of Xevinapant trials Research Report on Xevinapant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer Biospecimen Collection, Carboplatin, Chest Radiography - Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma | Phase 2 | Withdrawn | ECOG-ACRIN Cancer Research Group | 2024-04-12 | 2024-07-25 | |
| Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Xevinapant, Placebo - Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 13 | 2023-11-15 | 2026-08-20 |
Carcinoma (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
ECOG-ACRIN Cancer Research Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Norway (1) · Slovenia (1) · Spain (1) · United Kingdom (1)
Heath D Skinner (1) · Pierluigi Bonomo, Dr (1) · Sjoukje Oosting, Dr (1)
U10CA180820 (1)